Taiwan · Delayed Price · Currency is TWD GeneFerm Biotechnology Statistics
Total Valuation
TPEX:1796 has a market cap or net worth of TWD 1.23 billion. The enterprise value is 1.26 billion.
| Market Cap | 1.23B |
| Enterprise Value | 1.26B |
Important Dates
The next estimated earnings date is Tuesday, November 10, 2026.
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | Jul 14, 2026 |
Share Statistics
TPEX:1796 has 41.46 million shares outstanding. The number of shares has increased by 0.10% in one year.
| Current Share Class | 41.46M |
| Shares Outstanding | 41.46M |
| Shares Change (YoY) | +0.10% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 9.52% |
| Owned by Institutions (%) | n/a |
| Float | 20.67M |
Valuation Ratios
The trailing PE ratio is 72.26.
| PE Ratio | 72.26 |
| Forward PE | n/a |
| PS Ratio | 1.85 |
| PB Ratio | 1.57 |
| P/TBV Ratio | 1.57 |
| P/FCF Ratio | 15.69 |
| P/OCF Ratio | 11.08 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.54, with an EV/FCF ratio of 16.08.
| EV / Earnings | 73.78 |
| EV / Sales | 1.89 |
| EV / EBITDA | 13.54 |
| EV / EBIT | 63.81 |
| EV / FCF | 16.08 |
Financial Position
The company has a current ratio of 3.12, with a Debt / Equity ratio of 0.40.
| Current Ratio | 3.12 |
| Quick Ratio | 1.92 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 3.36 |
| Debt / FCF | 3.99 |
| Interest Coverage | 3.19 |
Financial Efficiency
Return on equity (ROE) is 2.16% and return on invested capital (ROIC) is 1.96%.
| Return on Equity (ROE) | 2.16% |
| Return on Assets (ROA) | 0.98% |
| Return on Invested Capital (ROIC) | 1.96% |
| Return on Capital Employed (ROCE) | 1.83% |
| Weighted Average Cost of Capital (WACC) | 4.04% |
| Revenue Per Employee | 4.62M |
| Profits Per Employee | 118,563 |
| Employee Count | 144 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.57 |
Taxes
In the past 12 months, TPEX:1796 has paid 3.91 million in taxes.
| Income Tax | 3.91M |
| Effective Tax Rate | 18.63% |
Stock Price Statistics
The stock price has decreased by -31.51% in the last 52 weeks. The beta is 0.07, so TPEX:1796's price volatility has been lower than the market average.
| Beta (5Y) | 0.07 |
| 52-Week Price Change | -31.51% |
| 50-Day Moving Average | 32.36 |
| 200-Day Moving Average | 40.43 |
| Relative Strength Index (RSI) | 46.62 |
| Average Volume (20 Days) | 20,938 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:1796 had revenue of TWD 664.94 million and earned 17.07 million in profits. Earnings per share was 0.41.
| Revenue | 664.94M |
| Gross Profit | 170.94M |
| Operating Income | 19.74M |
| Pretax Income | 20.98M |
| Net Income | 17.07M |
| EBITDA | 85.71M |
| EBIT | 19.74M |
| Earnings Per Share (EPS) | 0.41 |
Balance Sheet
The company has 281.97 million in cash and 312.42 million in debt, with a net cash position of -30.45 million or -0.73 per share.
| Cash & Cash Equivalents | 281.97M |
| Total Debt | 312.42M |
| Net Cash | -30.45M |
| Net Cash Per Share | -0.73 |
| Equity (Book Value) | 783.91M |
| Book Value Per Share | 18.91 |
| Working Capital | 398.82M |
Cash Flow
In the last 12 months, operating cash flow was 110.99 million and capital expenditures -32.63 million, giving a free cash flow of 78.36 million.
| Operating Cash Flow | 110.99M |
| Capital Expenditures | -32.63M |
| Depreciation & Amortization | 65.97M |
| Net Borrowing | -39.86M |
| Free Cash Flow | 78.36M |
| FCF Per Share | 1.89 |
Margins
Gross margin is 25.71%, with operating and profit margins of 2.97% and 2.57%.
| Gross Margin | 25.71% |
| Operating Margin | 2.97% |
| Pretax Margin | 3.16% |
| Profit Margin | 2.57% |
| EBITDA Margin | 12.89% |
| EBIT Margin | 2.97% |
| FCF Margin | 11.78% |
Dividends & Yields
This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 2.31%.
| Dividend Per Share | 0.70 |
| Dividend Yield | 2.31% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | -0.10% |
| Shareholder Yield | 2.22% |
| Earnings Yield | 1.39% |
| FCF Yield | 6.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:1796 has an Altman Z-Score of 3.36 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.36 |
| Piotroski F-Score | 7 |